Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Highly Purified Chondroitinase ABC from AMSBIO
Monday, September 16, 2013
Launch of new enzyme for neuroscience and regenerative medicine research.

Nanion Introduces New Product Family
Thursday, September 12, 2013
CardioExcyte 96 for cardiac toxicity profiling and screening.

CeMM and Haplogen Make Available the World’s Largest Collection of Human Cell Lines
Monday, September 02, 2013
Haplogen and CeMM partnership will distribute requested cell lines to the research community.

Energy Efficient Freeze Drying Enhances Pharmaceutical Production
Monday, August 19, 2013
New technical brief from SP Scientific on Hull freeze drying systems.

2D Code Reader Offers Unmatched Data Integrity
Wednesday, August 14, 2013
New Tracxer Code Reader TS201 from Micronic.

The Biobanking Community to Increasingly Require Innovative Products in Bio-Storage Applications
Tuesday, August 06, 2013
Long-term storage of clinical samples will be critical to the growth of biobanking.

Thermo Fisher Scientific Expands Water Purification Portfolio
Thursday, August 01, 2013
Advanced dispensing technology increases flexibility and ease-of-use for shared lab environments.

Life Technologies Makes Automated Cell Imaging Accessible to All Labs
Thursday, July 18, 2013
The EVOS® FL Auto Imaging System and on-stage incubator enables ease-of-use and broad applications for fluorescence microscopy on single integrated platform.

CDI Expands MyCell Products Line
Monday, July 15, 2013
Offers access to human disease models and licensing key genetic engineering patents.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 479
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv